|
|
Angiotech is a global specialty pharmaceutical and medical device company that discovers, develops, and markets innovative technologies and medical products primarily for local diseases or for complications associated with medical device implants, surgical interventions and acute injury.
Ticker: |
ANPI |
ISIN: |
CA0349181028 |
Address: |
1618 Station Street, Canada, Vancouver BC, V6A 1B6 |
Website: |
Angiotech Pharmaceuticals, Inc. |
Phone Number: |
604 221-7676 |
|
Basic corporate social responsibility ratingsData sources for this companyRatings history Subcategory CSR ratings
| | Governance | Community |
|---|
| Board | Leadership Ethics | Transparency & Reporting | Community Dev & Philanthropy | Product | Human Rights & Supply Chain |
|---|
| Angiotech Pharmaceuticals, Inc. | | | | | | |
| Pharmaceutical & Medicine Manufacturing | | | | | | |
| CSRHub average | 52 | 52 | 48 | 47 | 45 | 51 |
| Canada | | | | | | |
| | Employees | Environment |
|---|
| Compensation & Benefits | Diversity & Labor Rights | Training, Health & Safety | Energy & Climate Change | Policy & Reporting | Resource Management |
|---|
| Angiotech Pharmaceuticals, Inc. | | | | | | |
| Pharmaceutical & Medicine Manufacturing | | | | | | |
| CSRHub Average | 43 | 47 | 47 | 44 | 46 | 46 |
| Canada | | | | | | |
Name variants
|
|
